Lawmakers asked pointed questions of manufacturers and pharmacy benefit managers as they sought to understand the factors driving insulin price increases during a House committee hearing Wednesday, and members of both parties vowed to work together on legislation to ensure people have access to the medication they need.
House lawmakers explore drivers behind insulin price increases
Sign up for DiabetesPro SmartBrief
News for diabetes health professionals
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.